The pharmacological effects of morroniside and loganin isolated from liuweidihuang wan, on MC3T3-E1 cells

Molecules

Volumn 15, Issue 10, 2010, Pages 7403-7414

  Li, Manyu ^a   Wang, Wei ^a   Wang, Ping ^a   Yang, Kun ^a   Sun, Hui ^a   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Liuweidihuang wan; Loganin; MC3T3 E1; Morroniside; Osteoporosis

Indexed keywords

GLYCOSIDE; HERBACEOUS AGENT; IRIDOID; LIU WEI DI HUANG WAN; LIU-WEI-DI-HUANG WAN; LOGANIN; MORRONISIDE;

ANIMAL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CHEMISTRY; DRUG EFFECT; FEMALE; HUMAN; MALE; MOUSE; POSTMENOPAUSE OSTEOPOROSIS;

3T3 CELLS; ANIMALS; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; FEMALE; GLYCOSIDES; HUMANS; IRIDOIDS; MALE; MICE; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 78149418351     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15107403     Document Type: Article

References (38)

1. Lane, N.E. Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 2006, 194, S3-S11.
2. Sambrook, P.; Cooper, C. Osteoporosis. Lancet 2006, 367, 2010-2018.
3. Reginster, J.Y.; Burlet, N. Osteoporosis: A still increasing prevalence. Bone 2006, 38, S4-S9.
4. Cummings, S.R.; Melton, L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359, 1761-1767.
5. Johnell, O., Kanis, J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis Int. 2006, 17, 1726-1733.
6. Ross, P.D. Osteoporosis. Frequency, consequences, and risk factors. Arch. Intern. Med. 1996, 156, 1399-1411.
7. Dennison, E.; Mohamed, M.A.; Cooper, C. Epidemiology of osteoporosis. Rheum. Dis. Clin. N. Amer. 2006, 32, 617-629.
8. Raisz, L.G. Pathogenesis of osteoporosis: Concepts, conflicts and prospects. J. Clin. Invest. 2005, 115, 3318-3325.
9. Lindsay, R.; Hart, D.M.; Forrest, C.; Baird, C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980, 2, 1151-1154.
10. Jin, U.H.; Kim, D.I.; Lee, T.K. Herbal formulation, Yukmi-jihang-tang- Jahage, regulates bone resorption by inhibition of phosphorylation mediated by tyrosine kinase Src and cyclooxygenase expression. J. Ethnopharmacol. 2006, 106, 333-343.
11. Wang, X.J.; Sun, W.J.; Zhang, N.; Sun, H.; Geng, F.; Piao, C.Y. Isolation and identification of constituents absorbed into blood after oral administration of Liuwei Dihuang Wan. Chin. J. Nat. Med. 2007, 15, 277-280.
12. Wang, X.J.; Zhang, N.; Sun, H.; Sun, W.J. Studies on serum pharmacochemistry of Liuweidihuang Wan. Chin. J. Nat. Med. 2004, 2, 219-222.
13. Wang, X.J.; Zhang, N.; Sun, H.; Li, L.J.; Lv, H.T. The protective effect of LW constituents absorbed into blood on the rat model of shen deficiency induced by hydrocortisone. China J. Exp. Trad. Med. Formulae 2008, 14, 33-37.
14. Guan, J.; Tang, J.F.; Guo, R.L. The interfere effects of LW on the bone density in PO patients. Hainan Med. 2009, 20, 79-80.
15. Han, X.H.; Wang, S.M.; Zhang, N.Z. The effects of LW on the biomechanics characteristics and the contents of Ca, P in osteoporotic rat model. Pharmacol. Clin. Chinese Mater. Med. 2002, 18, 1-3.
16. Chen, T. The effects of aqueous extract of Fructus Corni on the bone morphology in mice model of osteoporosis. Tianjin Pharm. 2003, 15, 5-6.
17. Ducy, P.; Schinke, T.; Karsenty, G. The osteoblast: A sophisticated fibroblast under central surveillance. Science 2000, 289, 1501-1504.
18. Karsenty, G. Role of Cbfa1 in osteoblast differentiation and function. Semin. Cell Dev. Biol. 2000, 11, 343-346.
19. Schwartzman, R.A.; Cidlowski, J.A. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr. Rev. 1993, 14, 133-135.
20. Israels, L.G.; Israels, E.D. Apoptosis. Stem Cells 1999, 17, 306-313.
21. Cross, T.G.; Scheel, T.D.; Henriquez, N.V.; Deacon, E.; Salmon, M.; Lord, J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 2000, 256, 34-41.
22. Loeffler, M.; Kroemer, G. The mitochondrion in cell death control: Certainties and incognita. Exp. Cell Res. 2000, 256, 19-26.
23. Manolagas, S.C.; Jilka, R.L. Bone marrow, cytokines, and bone remodeling.Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 1995, 332, 305-311.
24. Jilka, R.L.; Weinstein, R.S.; Bellido, T.; Parfitt, A.M.; Manolagas, S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. 1998, 13, 793-802.
25. Jilka, R.L.; Weinstein, R.S.; Bellido, T.; Roberson, P.; Parfitt, A.M.; Manolagas, S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 1999, 104, 439-446.
26. Cohen, G.M. Caspases: The executioners of apoptosis. J. Biochem. 1997, 326, 1-16.
27. Cory, S.; Adams, J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2, 647-656.
28. Chua, C.C.; Chua, B.H.; Chen, Z.; Landy, C.; Hamdy, R.C. Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells. Biochem. Biophys. Acta 2003, 1642, 79-85.
29. Liu, Y.; Porta, A.; Peng, X.; Gengaro, K.; Cunningham, E.B.; Li, H.; Dominguez, L.A.; Bellido, T.; Christakos, S. Prevention of glucocorticoid- induced apoptosis in osteocytes and osteoblasts by calbindin-D28k. J. Bone Miner. Res. 2004, 19, 479-490.
30. Deveraux, Q.L.; Reed, J.C. IAP, family proteins - suppressors of apoptosis. Genes Dev. 1999, 13, 239-252.
31. Hu, S.; Yang, X. Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J. Biol. Chem. 2003, 278, 10055-10060.
32. Takahashi, N.; Udagawa, N.; Suda, T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 1999, 256, 449-455.
33. Amudeswari, S.; Liang, J.N.; Chakrabarti, B. Polar-apolar characteristics and fibrillogenesis of glycosylated collagen. Coll. Relat. Res. 1987, 7, 215-223.
34. Weinstein, R.S.; Manolagas, S.C. Apoptosis and osteoporosis. Amer. J. Med. 2000, 108,153-164.
35. Knott, L.; Whitehead, C.C.; Fleming, R.H.; Bailey, A.J. Biochemical changes in the collagenous matrix of osteoporotic avian bone. Biochem. J. 1995, 310, 1045-1051.
36. Turner, R.T.; Backup, P.; Sherman, P.J.; Hill, E.; Evans, G.L.; Spelsberg, T.C. Mechanism of action of estrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity. Endocrinology 1992, 131, 883-889.
37. Boyle, W.J.; Kung, Y.; Lacey, D.L. Osteoprotegerin ligand is required for murine osteoclasto genesis. Bone 1998, 23, 189.
38. Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China; Chemical Industry Press: Beijing, China, 2005; pp. 401-402.